CN102574892A - 抗生素复合物 - Google Patents
抗生素复合物 Download PDFInfo
- Publication number
- CN102574892A CN102574892A CN2010800483098A CN201080048309A CN102574892A CN 102574892 A CN102574892 A CN 102574892A CN 2010800483098 A CN2010800483098 A CN 2010800483098A CN 201080048309 A CN201080048309 A CN 201080048309A CN 102574892 A CN102574892 A CN 102574892A
- Authority
- CN
- China
- Prior art keywords
- compound
- chemical formula
- bacterium
- resistance
- belongs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
- C07D513/18—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
- C07K5/101—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
信号(signal) | □ | 信号 | □ | 信号 | □ |
1 | 12.11 | 25 | 64.45 | 49 | 144.61 |
2 | 13.74 | 26 | 64.73 | 50 | 148.17 |
3 | 14.1 | 27 | 65.69 | 51 | 148.45 |
4 | 14.8 | 28 | 65.95 | 52 | 151.89 |
5 | 16.48 | 29 | 70.27 | 53 | 152.76 |
6 | 17.11 | 30 | 77.1 | 54 | 155.45 |
7 | 17.27 | 31 | 101.45 | 55 | 157.9 |
8 | 17.55 | 32 | 101.45 | 56 | 159.0 |
9 | 20.9 | 33 | 102.6 | 57 | 160.04 |
10 | 23.13 | 34 | 116.52 | 58 | 160.36 |
11 | 27.56 | 35 | 120.63 | 59 | 161.01 |
12 | 27.56 | 36 | 121.59 | 60 | 163.75 |
13 | 29.04 | 37 | 123.28 | 61 | 164.46 |
14 | 33.24 | 38 | 123.87 | 62 | 164.5 |
15 | 46.17 | 39 | 123.87 | 63 | 166.6 |
16 | 50.14 | 40 | 125.48 | 64 | 167.13 |
17 | 51.3 | 41 | 126.03 | 65 | 167.95 |
18 | 53.91 | 42 | 126.69 | 66 | 168.47 |
19 | 53.91 | 43 | 128.24 | 67 | 168.67 |
20 | 55.8 | 44 | 130.34 | 68 | 170.35 |
21 | 57.32 | 45 | 130.98 | 69 | 170.35 |
22 | 58.8 | 46 | 131.14 | 70 | 171.63 |
23 | 62.42 | 47 | 132.39 | 71 | 172.0 |
24 | 62.73 | 48 | 141.85 |
Claims (19)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US23918609P | 2009-09-02 | 2009-09-02 | |
US61/239,186 | 2009-09-02 | ||
PCT/IB2010/053897 WO2011027290A1 (en) | 2009-09-02 | 2010-08-31 | Antibiotic compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102574892A true CN102574892A (zh) | 2012-07-11 |
CN102574892B CN102574892B (zh) | 2014-12-17 |
Family
ID=42990204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201080048309.8A Expired - Fee Related CN102574892B (zh) | 2009-09-02 | 2010-08-31 | 抗生素复合物 |
Country Status (14)
Country | Link |
---|---|
US (2) | US10501492B2 (zh) |
EP (1) | EP2473516A1 (zh) |
JP (1) | JP2013503624A (zh) |
KR (1) | KR20120093192A (zh) |
CN (1) | CN102574892B (zh) |
AU (1) | AU2010290872B2 (zh) |
BR (1) | BR112012004643A2 (zh) |
CA (1) | CA2772742A1 (zh) |
IL (1) | IL218478A0 (zh) |
MX (1) | MX2012002619A (zh) |
NZ (1) | NZ599175A (zh) |
RU (1) | RU2536587C2 (zh) |
WO (1) | WO2011027290A1 (zh) |
ZA (1) | ZA201202350B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2013001325A (es) | 2010-08-05 | 2013-10-28 | Piramal Entpr Ltd | Formulacion de microparticulas para la administracion pulmonar de farmacos de moleculas anti-infecciosas para el tratamiento de enfermedades infecciosas. |
JP5975000B2 (ja) * | 2013-08-30 | 2016-08-23 | 株式会社ツムラ | 微生物検出方法 |
WO2015107482A1 (en) * | 2014-01-17 | 2015-07-23 | Piramal Enterprises Limited | Pharmaceutical combination for treatment of tuberculosis |
JP6465299B2 (ja) * | 2015-05-29 | 2019-02-06 | 株式会社山田養蜂場本社 | 蜂蜜画分 |
US20220081470A1 (en) * | 2019-01-05 | 2022-03-17 | Foundation For Neglected Disease Research | Thiazolyl peptides for the treatment nontuberculous mycobacterial infections |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN87108341A (zh) * | 1986-12-15 | 1988-08-10 | 伊莱利利公司 | 抗生素a10255复合物和诸因子及其工艺规程,微生物,和生产方法 |
WO2002066046A1 (en) * | 2001-02-20 | 2002-08-29 | Jonghee Kim | Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2982689A (en) | 1955-03-01 | 1961-05-02 | Olin Mathieson | Thiostrepton, its salts, and production |
EP2010202B1 (en) | 2006-04-18 | 2013-09-25 | Piramal Enterprises Limited | Antibacterial compounds |
WO2009115287A1 (de) * | 2008-03-17 | 2009-09-24 | Technische Universität Dortmund | Thiostrepton-derivate |
UA91725C2 (ru) * | 2008-05-12 | 2010-08-25 | Львовский Национальный Университет Им. Ивана Франка | Способ обнаружения антибиотиков тиострептонового ряда |
-
2010
- 2010-08-31 JP JP2012527433A patent/JP2013503624A/ja active Pending
- 2010-08-31 CA CA2772742A patent/CA2772742A1/en not_active Abandoned
- 2010-08-31 RU RU2012112366/04A patent/RU2536587C2/ru not_active IP Right Cessation
- 2010-08-31 MX MX2012002619A patent/MX2012002619A/es active IP Right Grant
- 2010-08-31 CN CN201080048309.8A patent/CN102574892B/zh not_active Expired - Fee Related
- 2010-08-31 AU AU2010290872A patent/AU2010290872B2/en not_active Expired - Fee Related
- 2010-08-31 KR KR1020127008552A patent/KR20120093192A/ko not_active Application Discontinuation
- 2010-08-31 BR BR112012004643A patent/BR112012004643A2/pt not_active IP Right Cessation
- 2010-08-31 EP EP10763435A patent/EP2473516A1/en not_active Withdrawn
- 2010-08-31 NZ NZ599175A patent/NZ599175A/xx not_active IP Right Cessation
- 2010-08-31 US US13/393,294 patent/US10501492B2/en active Active
- 2010-08-31 WO PCT/IB2010/053897 patent/WO2011027290A1/en active Application Filing
-
2012
- 2012-03-04 IL IL218478A patent/IL218478A0/en unknown
- 2012-03-30 ZA ZA2012/02350A patent/ZA201202350B/en unknown
-
2014
- 2014-08-08 US US14/454,974 patent/US20140348919A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN87108341A (zh) * | 1986-12-15 | 1988-08-10 | 伊莱利利公司 | 抗生素a10255复合物和诸因子及其工艺规程,微生物,和生产方法 |
WO2002066046A1 (en) * | 2001-02-20 | 2002-08-29 | Jonghee Kim | Cancer therapeutic agent comprising thiopeptide with multiple thiazole rings |
Non-Patent Citations (4)
Title |
---|
AYIDA BK ET AL.: "Synthesis of dehydroalanine fragments as thiostrepton side chain mimetics", 《BIOORGANIC & MEDICINAL CHEMISTRY LETTERS》 * |
K C NICOLAOU ET AL.: "Total Synthesis of Thiostrepton, Part 2: Construction of the Quinaldic Acid Macrocycle and Final Stages of the Synthesis", 《ANGEWANDTE CHEMIE INTERNATIONAL EDITION》 * |
TOMONORI MORI ET AL.: "Synthetic studies on thiostrepton family of peptide antibiotics: synthesis of the cyclic core portion containing the dehydropiperidine, dihydroquinoline, l-valine, and masked dehydroalanine segments", 《TETRAHEDRON LETTERS》 * |
TOMONORI MORI ET AL.: "Total synthesis of siomycin A", 《TETRAHEDRON LETTERS》 * |
Also Published As
Publication number | Publication date |
---|---|
AU2010290872B2 (en) | 2015-06-11 |
WO2011027290A1 (en) | 2011-03-10 |
US20140348919A1 (en) | 2014-11-27 |
NZ599175A (en) | 2013-05-31 |
AU2010290872A1 (en) | 2012-04-26 |
JP2013503624A (ja) | 2013-02-04 |
CN102574892B (zh) | 2014-12-17 |
RU2536587C2 (ru) | 2014-12-27 |
BR112012004643A2 (pt) | 2019-09-24 |
IL218478A0 (en) | 2012-04-30 |
KR20120093192A (ko) | 2012-08-22 |
CA2772742A1 (en) | 2011-03-10 |
MX2012002619A (es) | 2012-06-25 |
RU2012112366A (ru) | 2013-11-10 |
EP2473516A1 (en) | 2012-07-11 |
US10501492B2 (en) | 2019-12-10 |
ZA201202350B (en) | 2015-05-27 |
US20120156295A1 (en) | 2012-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5907931B2 (ja) | チアクマイシン生産 | |
Chen et al. | Three antimycobacterial metabolites identified from a marine-derived Streptomyces sp. MS100061 | |
CN102574892B (zh) | 抗生素复合物 | |
US20070191415A1 (en) | Production of tacrolimus (fk-506) using new streptomyces species | |
CN101563353B (zh) | 氨基噻唑大环类、它们作为抗菌化合物的用途以及制备它们的方法 | |
Veilumuthu et al. | Antimicrobial compounds produced by Streptomyces sp. VITGV01 against selected human pathogens | |
JP5283927B2 (ja) | 新規化合物アミコラマイシン、その製造方法及びその用途 | |
CN101735149B (zh) | 具有抗菌和抗肿瘤活性的大环酰胺化合物及其制备方法与应用 | |
KR20090036544A (ko) | 신규한 항균성 화합물 | |
US5028536A (en) | Antitumor antibiotic BMY-41339 | |
WO2010122669A1 (ja) | 新規化合物アミコラマイシン、その製造方法及びその用途 | |
US4137224A (en) | Process for the preparation of antibiotic W-10 complex and for the isolation of antibiotic 20561 and antibiotic 20562 therefrom | |
CN112899199B (zh) | 一种小单孢菌tmd166及其应用 | |
US4232006A (en) | Antibiotic W-10 complex, antibiotic 20561 and antibiotic 20562 as antifungal agents | |
US5086045A (en) | Antitumor antibiotic | |
US4230799A (en) | Process for the preparation of antibiotic W-10 complex and for the isolation of Antibiotic 20561 and Antibiotic 20562 therefrom | |
JPH0368583A (ja) | 新規微生物変換物質 | |
Li | 11-Chloro-resistoflavin, An Active Antibiotic Against Methicillin-Resistant Staphylococcus Aureus (MRSA) Discovered from Streptomyces Collected on North Egyptian Coast | |
US8318684B2 (en) | Antibiotics, bispolides A1, A2, and A3 as well as bispolides B1, B2a, B2b and B3 and processes for producing said antibiotics | |
Jayanthi et al. | Profiling of red pigment produced by Streptomyces sp. JAR6 and its bioactivity | |
WO1990009435A1 (en) | Altromycin compounds | |
JP2000086627A (ja) | 抗菌性物質be−54476及びその製造法 | |
Attafuah | An investigation into some antibiotics produced by Pseudomonas antimicrobica | |
CA2041815A1 (en) | Altromycin compounds | |
JP2003286288A (ja) | 新規抗生物質sf2811物質、その製造法およびその用途 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: PIRAMAL HEALTHCARE UK LTMITED Free format text: FORMER OWNER: NICHOLAS PIRAMAL INDIA LTD. Effective date: 20130306 |
|
C41 | Transfer of patent application or patent right or utility model | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Lower Lamar building, lower Mumbai, India Applicant after: PIRAMAL ENTERPRISES LTD. Address before: Lower Lamar building, lower Mumbai, India Applicant before: Piramal healthcare Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: PIRAMAL HEALTHCARE UK LTMITED TO: PIRAMAL ENTERPRISES LTD. |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20130306 Address after: Lower Lamar building, lower Mumbai, India Applicant after: Piramal healthcare Ltd. Address before: Mumbai Applicant before: Piramal Life Sciences Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141217 Termination date: 20150831 |
|
EXPY | Termination of patent right or utility model |